LAUSANNE, Switzerland and SAN FRANCISCO, July 16, 2021 /PRNewswire/ -- Asceneuron SA, a clinical stage company dedicated to targeting the root cause of neurodegenerative diseases, announced today the appointment of Catherine Moukheibir to its Board of Directors. Catherine is a highly...
from PR Newswire: https://ift.tt/36K20VK
No comments:
Post a Comment